共 50 条
- [21] Safety Of Remission Induction With Rituximab Versus Cyclosphosphamide In Patients 65 and Older With Severe ANCA-Associated Vasculitis ARTHRITIS AND RHEUMATISM, 2013, 65 : S313 - S313
- [22] Reduced-dose vs high-dose glucocorticoids added to rituximab and remission induction in ANCA-associated vasculitis (vol 326, pg 1536, 2021) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1697 - 1697